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Fres isolated blood cells recombined with normal heparinized plasma and then incubated with endotoxin, 
induced a lOO-fold increase in monocyte tissue thromboplastin synthesis. In contrast, recombination of 
these cells with heat inactivated plasma, cobra venom factor-treated plasma, Ca2 + -free plasma, or BioRex 
70-treated plasma (plasma free of Clq and D) before incubation with endotoxin, failed to induce monocyte 
synthesis of tissue thromboplastin. These results strongly support the hypothesis that complement is 
required for endotoxin stimulation of blood monocyte synthesis of tissue thromboplastin. 
Monocyte Thromboplastin synthesis Complement Endotoxin 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Bacterial lipopolysaccharides (endotoxins) in- 
duce tissue thromboplastin synthesis in monocytes 
[l-3]. We have found that 75% of the newly syn- 
thesized thromboplastin becomes available on the 
surface of the monocytes [4], and thereby may 
cause a rapid and highly potent activation of the 
coagulation system leading to severe disseminated 
intravascular coagulation in septicaemia [5]. 
2.1. Blood collection 
Human blood was collected into heparin 
(5 U/ml); 0.025 M EGTA + 0.025 M MgClz 
pH 7.4); 0.2% EDTA (pH 7.4); 0.01 M sodium 
citrate-citric acid (pH 7.4) [lo], in polycarbonate 
tubes. These are all final concentrations of the 
anticoagulants. 
In addition to endotoxins, a variety of com- 
ponents such as lectins, immune-complexes, 
allogeneic cells, CSa and C3b, have all been stated 
to induce a procoagulant activity (probably tissue 
thrombloplastin) in isolated monocytes [6-lo]. 
2.2. Isolation and thromboplastin quantitation 
of mononuclear cells 
However, experiments with monocytes in cell 
cultures incubated with endotoxin in the presence 
and absence of anti-C5 antibodies, showed no in- 
hibitory effect of the antibody [9]. These in- 
vestigators excluded therefore the complement 
components C5-C9 as a mediator of the endotoxin 
on monocytes. 
This investigation concludes that the endotoxin 
effect is dependent on the complement system. In 
contrast to previous reports our results are obtain- 
ed by using unmodified monocytes; i.e., newly 
drawn blood monocytes recombined with plasma 
subjected to various treatments. 
Mononuclear cells were isolated on Lympho- 
paque (a gift from Nyegaard, Oslo) as in [l]. The 
cells were washed once by resuspending the band 
containing the mononuclear cells in 0.15 M NaCl 
and collected by centrifugation at 1500 x g for 
10 min. These cell preparations contained - 30% 
monocytes and 70% lymphocytes and some plate- 
lets. The cell sediment for 1 ml blood was resus- 
pended in 0.15 M NaCl, and the amount of tissue 
thromboplastin in the monocytes after freezing 
and thawing was determined by incubating the test 
sample with purified factor VII and factor X as in 
[ 121. The factor Xa activity generated in these in- 
cubation mixtures was measured with a clotting 
assay. This activity was then related to the factor 
Xa activity obtained in the same system by testing 
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dilutions of a crude tissue thromboplastin prepara- 
tion from human brain [4]. The undiluted throm- 
boplastin was defined as 100% activity. We have 
shown that only monocytes possess throm- 
boplastin activity [4]. Furthermore, the con- 
taminating lymphocytes and platelets had no effect 
on our assay system for thromboplastin activity 
[41* 
2.3. Endotoxin stimulation of monocytes 
Whole blood or blood cells (1 ml) recombined 
with plasma pretreated in various ways, in 1.3 
cm x 8.0 cm polycarbonate tubes was incubated 
with Escherichia coli 0.26 : B6 endotoxin (obtained 
from Difco Laboratories, Detroit MI) for 2 h (or 
various time-intervals) at 37°C. The mononuclear 
cells were then immediately isolated. A stock solu- 
tion of 4 mg endotoxin/ml was prepared by 
dissolving it in 0.15 M NaCl and kept at 4°C. In 
some experiments (indicated in section 3) endotox- 
ins from Sigma (St Louis MO) were used. 
2.4. Inactivation of complement factors in the 
alternative and classical path ways 
Heparinized blood was centrifuged at 3500 xg 
for 10 min at room-temperature. The plasma was 
pipetted off into plastic tubes. One part of the 
plasma was heated in the waterbath at 50°C for 
20 min to inactivate the B-component of the alter- 
native pathway. The other part of the plasma sam- 
ple was incubated at 56°C for 30 min to inactivate 
both the alternative and classical complement 
systems. 
2.5 Removal of plasma complement factor by 
BioRex chromatography 
To 5 ml heparinized plasma in polycarbonate 
tubes were added 0.5 g filtered BioRex 70 (Bio-Rad 
Labs., Richmond CA) that had been equilibrated 
with buffer composed to 0.082 M NaCI, 2 mM 
EDTA and 0.05 M sodium phosphate (pH 7.3) 
[15]. After stirring for 30 min the BioRex 70 was 
removed from the plasma by centrifugation at 
12000xg for 10 min. 
2.6. Cobra venom factor 
Anticomplementary factor from cobra venom 
was obtained from Cordis Labs. (Miami FL). In 
most of our experiments the venom from Naja 
naja kaouthia (cat.no. 750-007) was used. The 
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venom from Naja haje (cat.no. 750-005) was also 
tested, but this cobra venom factor had less effect 
than the venom from Naja naja kaouthia. 
3. RESULTS 
3.1. Requirement of Ca2+ in endotoxin-induced 
synthesis of tissue thromboplastin in mono- 
cytes in blood 
Table 1 shows that EDTA and EGTA as anti- 
coagulants block the effect of endotoxin on 
monocytes in whole blood. As shown in [4], en- 
dotoxin is capable of inducing thromboplastin syn- 
thesis in monocytes of citrate blood. However, 
compared with thromboplastin activity in mono- 
cytes of heparinized blood incubated with endo- 
toxin (see fig. l), a substantial inhibition of the 
endotoxin effect is also caused by citrate anti- 
coagulant. 
Table 1 
The tissue thromboplastin activity of monocytes isolated 
from blood collected into various anticoagulants, and 
incubated with endotoxin 
Endotoxin 
@g/ml) 
Tissue thromboplastin activity/lo3 
EDTA EGTA + Citrate 
MgCl2 
0.050 0.14 0.05 1.9 
0.5 0.30 0.05 6.6 
5.0 0.07 0.07 12.0 
50.0 0.09 0.04 20.0 
Blood samples (1 ml) in 0.2% Naz EDTA (pH 7.4) or 
0.025 M EGTA + 0.025 M MgC12 (pH 7.4) or 0.01 M 
sodium citrate-citric acid (pH 7.4) (final cont.) were in- 
cubated with various concentrations of endotoxin for 
2 h at 37°C. The mononuclear cells were isolated and 
their thromboplastin activity measured 
Fig. 1 illustrates the effect of incubating 1 ng en- 
dotoxin/ml heparin blood of 4 normal donors. A 
remarkable variation among individual responses 
to endotoxin is seen. The blood donor with the 
highest response to endotoxin was routinely 
observed even to generate some tissue throm- 
boplastin in the monocytes of heparinized blood- 
samples incubated in the absence of endotoxin. 
Blood from the same donors were also incubated 
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Fig. 1. The synthesis of tissue thromboplastin in 
monocytes of heparinized blood from 4 donors in- 
cubated with 1 ng endotoxin/ml at 37°C. At the time- 
intervals shown, 1 ml blood samples were pipetted off 
and the mononuclear cells isolated. The monocyte 
numbers (17) in the test samples were not significantly 
different. 
with PHA and other endotoxins (E. coli 0111: 34, 
E. coli 0121: B8, Salmonella enteridis, Salmonella 
typhosa, and Serratia marcescens) and the same 
responses were seen with these stimulating agents. 
3.2. Failure of endotoxin to induce synthesis of 
tissue thromboplastin in monocytes in heat- 
-inactivated plasma 
Blood cells were separated and recombined with 
either fresh untreated plasma, or plasma either in- 
cubated at 50°C for 20 min or 56°C for 30 min. 
The recombined samples were then subjected to in- 
cubation with endotoxin for 2 h. The monocytes of 
the incubated samples were isolated and the throm- 
boplastin content quantitated. The average results 
of 4 expt were as follows. When plasma had been 
incubated at 56”C, 50°C or 20°C the resultant 
activities of thromboplastin were, respectively, 
1.4 + 1.9/103, 10.0 + 2.7/103 and 17.1 f 4.2/103 
per lo6 monocytes, as expressed in percentage of 
our crude human standard tissue thromboplastin. 
Thus heat inactivation at 56°C for 30 min of the 
plasma abolished the endotoxin effect on the 
monocytes. The heat treatment is known to destroy 
the complement activity in plasma. Heat inactiva- 
tion of plasma at 50°C for 20 min, a procedure 
known to destroy the activity of the alternative 
pathway in the complement system, partially re- 
FRESH PLASMA(%) 
Fig. 2. The requirement of fresh plasma for the induc- 
tion of tissue thromboplastin synthesis in endotoxin- 
stimulated monocytes. Washed blood cells were recom- 
bined with heat-inactivated plasma (56°C for 30 min) 
mixed with increasing ratio of fresh plasma, and in- 
cubated for 2 h with 0.5 rg endotoxin/ml at 37°C. Then 
the mononuclear cells were isolated and their throm- 
boplastin content measured. Monocytes counts were per- 
formed on each sample, but no change in the recovery of 
monocyte of the different blood samples was observed. 
moved the stimulating effect of endotoxin in 
blood. 
The necessity for fresh plasma in order to obtain 
a stimulating effect of endotoxin on the synthesis 
of tissue thromboplastin is shown in fig. 2. An 
almost linear relationship was found between the 
amount of tissue thromboplastin and the amount 
of fresh plasma present in the incubation mixture 
of the blood cells and endotoxin. 
3.3. The effect of endotoxin on blood cells in 
plasma depleted of complement factors by 
cobra venom factor or adsorption with 
BioRex 70-resin 
Plasma was incubated with various concentra- 
tions of cobra venom factor (CVF) for 3 h at 37°C. 
Such plasma was then combined with washed 
blood cells and incubated with 0.5 ,ug endo- 
toxin/ml for 2 h. After the incubation, the mono- 
nuclear cells were isolated and their content of 
tissue thromboplastin determined. The following 
results were found: 40+-5.3/103, 8.1 +3.1/103, 
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5.1 *2.3/103 and 3.1 f 1.5/103 thromboplastin 
activity per lo6 monocytes, as expressed in percen- 
tage of our crude human standard tissue throm- 
boplastin (av. 3 expt). These values correspond to 
the value found in blood cells recombined, either 
with untreated plasma or plasma preincubated 
with 1.0, 2.0 and 4.0 U cobra venom factor/ml, 
respectively. 
After removal of factor D and Clq from plasma 
by chromatography on BioRex 70 [13], the en- 
dotoxin failed to induce the synthesis of tissue 
thromboplastin when washed blood cells were 
recombined with this plasma (table 2). A small ac- 
tivation seems to occur following washing the cells 
as seen from lines 2 and 4 of table 2. This activa- 
tion may account for most of the activity in the test 
sample shown in line 5. 
Table 2 
The effect of endotoxin on blood cells recombined with 
normal plasma and subjected to chromatography on 
Bio-Rex 70 
Test samples Tissue 
thromboplastin 
activity/ lo3 
Blood + endotoxin 
Blood + 0.15 M NaCl 
Blood-cells + plasma 
+ endotoxin 
Blood-cells + plasma 
+ 0.15 M NaCl 
Blood-cells + Bio-Rex 70- 
absorbed plasma 
+ endotoxin 
Blood cells + Bio-Rex 70- 
absorbed plasma 
+ 0.15 M NaCl 
34.8 
0.3 
32.1 
2.5 
3.9 
1.4 
Blood (1 ml) or combined samples of 0.5 ml washed 
blood-cells + 0.5 ml fresh plasma or Bio-Rex 70- 
absorbed plasma were incubated with (0.5 pug/ml) or 
without endotoxin for 2 h at 37°C. The mononuclear 
cells were isolated and their tissue thromboplastin 
content measured 
4. DISCUSSION 
These results show for the first time evidence for 
a mandatory role of complement factors in the 
endotoxin-induced synthesis of tissue throm- 
boplastin in monocytes in whole blood. The find- 
ing that monocytes, in the absence of plasma fac- 
tors, or in the presence of 56°C heat-inactivated 
plasma, CVF-treated plasma, or BioRex 70-ab- 
sorbed plasma, failed to produce tissue throm- 
boplastin when incubated with endotoxin, strongly 
suggest o us a requirement for complement factors 
in this reaction. The need for Ca2+ also supports 
this hypothesis. The low activity generated in 
titrated blood incubated with endotoxin as com- 
pared to heparinized blood, probably indicates 
that there is sufficient free Ca2+ on the surface of 
the cells. 
No effect of anti-C5 antibody was shown in 
monocyte-plasma system incubated with endotox- 
in [9]. However, the anti-C5 antibodies do not in- 
hibit the initial steps in the complement cascade. 
Furthermore, the initial formation of antibody- 
antigen complexes may also activate the comple- 
ment system before full neutralization of C5 is 
obtained. 
A direct effect of endotoxin on monocytes has 
been shown in [l-3,14-16]. However, these 
experiments have all been carried out in cell 
cultures where the monocytes probably already 
have changed their properties. Cultured monocytes 
are known to produce complement factors, which 
could account for the endotoxin effect in the 
absence of an external complement source. Con- 
ceivably, cultured monocytes might be induced to 
synthesize tissue thromboplastin in the total 
absence of complement, in contrast to freshly 
drawn blood monocytes. 
Our experiments indicate that the complement 
system is important for inducing activation of the 
coagulation system by its interaction with the 
monocytes. This event, resulting in exposed throm- 
boplastin on the surface of the monocytes, is pro- 
bably the only cause of the fulminant reactions 
seen in some Gram-negative septicaemia patients. 
Furthermore, preliminary data have revealed that 
thrombin through its activation of complement is 
capable of inducing tissue thromboplastin syn- 
thesis in monocytes. This mechanism for throm- 
boplastin generation is now being explored. 
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